| Identification | Back Directory | [Name]
iMDK | [CAS]
881970-80-5 | [Synonyms]
iMDK
3-[2-(4-Fluoro-benzyl)-imidazo[2,1-b]thiazol-6-yl]-chromen-2-one
2H-1-Benzopyran-2-one, 3-[2-[(4-fluorophenyl)methyl]imidazo[2,1-b]thiazol-6-yl]-
inhibit,iMDK,midkine,factor,PI3K,NSCLC,growth,Inhibitor,Phosphoinositide 3-kinase,MDK | [Molecular Formula]
C21H13FN2O2S | [MDL Number]
MFCD07528492 | [MOL File]
881970-80-5.mol | [Molecular Weight]
376.4 |
| Chemical Properties | Back Directory | [density ]
1.42±0.1 g/cm3(Predicted) | [storage temp. ]
Store at -20°C, protect from light | [solubility ]
Limited solubility | [form ]
Solid | [pka]
5.71±0.40(Predicted) | [color ]
Off-white to yellow |
| Hazard Information | Back Directory | [Uses]
iMDK is a small molecule inhibitor used to bind to midkine (MDK), a heparin binding growth factor that is expressed in malignant tumors. | [Biological Activity]
Cell permeable: yes''Primary Target
Midkine''Reversible: yes | [storage]
Store at +4°C |
|
| Company Name: |
Merck KGaA
|
| Tel: |
21-20338288 |
| Website: |
www.sigmaaldrich.cn |
|